Smad Inhibitors
Learn MoreBromodomain inhibitors are a class of compounds that have emerged as powerful tools in chemical biology and drug discovery These inhibitors specifically target bromodomain-containing proteins which play crucial roles in gene regulation and chromatin remodeling By blocking the interaction between bromodomain proteins and their binding partners bromodomain inhibitors can modulate gene expression and potentially treat a range of diseases including cancer and inflammatory conditions With their potential to target specific proteins and pathways bromodomain inhibitors offer exciting opportunities for therapeutic development Our company specializes in providing a diverse range of bromodomain inhibitors for research and development purposes
Catalog Number | Chemical Name | CAS # | Price |
---|---|---|---|
EI-0008 | (-)-JQ1 | 1268524-71-5 | Online Inquiry |
EI-0094 | ABBV-744 | 2138861-99-9 | Online Inquiry |
EI-0226 | ARV-771 | 1949837-12-0 | Online Inquiry |
EI-0227 | ARV-825 | 1818885-28-7 | Online Inquiry |
EI-0294 | AZD-5153 | 1869912-40-2 | Online Inquiry |
EI-0349 | BAZ2-ICR | 1665195-94-7 | Online Inquiry |
EI-0382 | BI-7273 | 1883429-21-7 | Online Inquiry |
EI-0385 | BI-9564 | 1883429-22-8 | Online Inquiry |
EI-0429 | BMS-986158 | 1800340-40-2 | Online Inquiry |
EI-0463 | Bromodomain Inhibitor, (+)-JQ1 | 1268524-70-4 | Online Inquiry |
EI-0464 | Bromosporine | 1619994-69-2 | Online Inquiry |
EI-0653 | CPI-203 | 1446144-04-2 | Online Inquiry |
EI-0716 | dBET6 | 1950634-92-0 | Online Inquiry |
EI-1066 | GNE-272 | 1936428-93-1 | Online Inquiry |
EI-1083 | GSK-046 | 2474876-09-8 | Online Inquiry |
Bromodomain inhibitors have significant applications in both research and medicine In the field of research these inhibitors are essential tools for studying epigenetic processes and the role of bromodomains in gene regulation By selectively targeting bromodomains scientists can unravel the intricate mechanisms underlying various diseases and potentially identify novel therapeutic targets
In medicine bromodomain inhibitors show promise in the treatment of cancer Many cancer cells rely on bromodomain-containing proteins for their survival and growth By inhibiting these proteins bromodomain inhibitors have the potential to disrupt the growth of cancer cells and enhance the effectiveness of existing anticancer therapies
Furthermore bromodomain inhibitors are being investigated for their potential in treating inflammation neurological disorders and cardiovascular diseases By targeting specific bromodomain-containing proteins involved in these conditions these inhibitors offer a promising avenue for therapeutic intervention
Overall the diverse applications of bromodomain inhibitors highlight their importance as a valuable tool in research as well as their potential to revolutionize treatment options in various medical fields
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.